Latest News for: ctos
Edit
As AI becomes pervasive, CTOs need to talk to clients and educate their bosses
Fast Company 22 Jan 2026
In my previous life as a technology journalist, I wrote and edited countless stories about corporate chief technology officers (CTOs) emerging as key partners to their counterparts in the C-suite.
Edit
Serial entrepreneurs Eilon Elhadad and Eylam Milner named Mamram Association’s CEOs and CTOs of the year
Ynet 03 Jan 2026
Edit
Citadel CTO says he personally calls top entry-level candidates who are deciding whether to join ...
Business Insider 05 Dec 2025
Umesh Subramanian says he reaches out to top candidates when they're in their decision-making process about joining the firm ... That includes not just senior-level recruits, but also recent grads, he said ... "And oftentimes we win those candidates." ... ....
Edit
PR No. 267 ALL LTOs, MTOs, CTOs, and RTOs TO REMIAN O (Ministry of Information and Broadcasting of the Islamic Republic of Pakistan)
Public Technologies 26 Nov 2025
Edit
The Tetravalent Death Receptor 5 Agonist Ozekibart (INBRX-109) in Conventional Chondrosarcoma: Results From the Randomized, Registrational, Phase 2 ChonDRAgon Study 21st Annual Industry/Academia Precision Oncology & Radmed Symposium (CTOS 2025 ChonDRAgon Primary Data Abstract Nov25Inhibrx 21st Annual Precision Oncology DR5 Agonist Clinical Data Nov25) (Inhibrx Biosciences Inc)
Public Technologies 14 Nov 2025
Edit
Translational Data and Significant Pathologic Response Rates from EFTISARC-NEO Phase II Highlighted in Oral Presentation at CTOS 2025 (Form 6-K) (Immutep Ltd)
Public Technologies 14 Nov 2025
EFTISARC-NEO Phase II Highlighted in Oral Presentation at CTOS 2025 • ... The CTOS 2025 oral presentation slides can be found on the Posters & Publications page of Immutep's website.
Edit
Translational Data and Significant Pathologic Response Rates from EFTISARC-NEO Phase II Highlighted in Oral Presentation at CTOS 2025 (Immutep Ltd)
Public Technologies 13 Nov 2025
) Translational Data and Significant Pathologic Response Rates from EFTISARC-NEO Phase II Highlighted in Oral Presentation at CTOS 2025 ... The CTOS 2025 oral presentation slides can be found on the Posters & Publications page of Immutep's website.
Edit
The Galveston Daily News
12 Nov 2025
Deciphera Announces Multiple Data Presentations at the Connective Tissue Oncology Society (CTOS) Annual Meeting 2025
Edit
CTOS 2025 Annual Meeting – EFTISARC-NEO trial of neoadjuvant soluble LAG-3 protein (Soft Tissue Sarcoma) (Immutep Ltd)
Public Technologies 12 Nov 2025
). The text version of this document is not available ... Attachments Permalink.
- 1